Stock Updates

Is Medivation, Inc.(NASDAQ: MDVN), a large market cap stock a smart buy?

With a market cap of has a large market cap size. Medivation, Inc. (NASDAQ: MDVN) has been on the stock market since its IPO date on the 1/13/1997. Medivation, Inc. is in the Biotechnology industry and Healthcare sector. Average volume for Medivation, Inc., is 3543.03, and so far today it has a volume of 6699400. Performance year to date since the 1/13/1997 is 67.42%.

To help you determine whether Medivation, Inc. is undervalued the following values will help you decide. P/E is *TBA and forward P/E is 37.18. PEG perhaps more useful shows that Medivation, Inc. has a value for PEG of *TBA. P/S ratio is 13.06 and the P/B ratio is 24.98. The P/Cash and P/Free cash flow is 40.98 and 44.07 respectively.

At the current price Medivation, Inc. is trading at, 80.93 (0.46% today), Medivation, Inc. has a dividend yield of *TBA, and this is covered by a payout ratio of *TBA. Earnings per share (EPS) is -1.17, and this is looking to grow in the next year to 71.15% after growing -11.10% this past year. EPS growth quarter over quarter is *TBA, and 17.40% for sales growth quarter over quarter.

The number of shares outstanding is 165.7, and the number of shares float is 163.77. The senior management bring insider ownership to 1.10%, and institutional ownership is at 91.20%. The float short is 1.50%, with the short ratio at a value of 0.7. Management has seen a return on assets of -13.00%, and also a return on investment of 27.10%.

The ability for Medivation, Inc., to deal with debt, means it current ratio is 4.3, and quick ratio is 4.3. Long term debt/equity is 0 and total debt/equity is 0. In terms of margins, Medivation, Inc. has a gross margin of *TBA, with its operating margin at -26.30%, and Medivation, Inc. has a profit margin of -17.20%.

The 52 week high is 0.32%, with 206.44% being its 52 week low. The 20 day simple moving average is 23.75% and the 200 day simple moving average is 60.47%.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.


About the author

Peter Clarke

Leave a Comment